Bath & Body Works (BBWI) – Research Analysts’ Weekly Ratings Updates

Bath & Body Works (NYSE: BBWI) recently received a number of ratings updates from brokerages and research firms:

• 4/22/2025 – Bath & Body Works had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $49.00 to $42.00. They now have a “buy” rating on the stock.
• 4/17/2025 – Bath & Body Works had its price target lowered by analysts at Raymond James from $46.00 to $37.00. They now have an “outperform” rating on the stock.
• 4/14/2025 – Bath & Body Works had its price target lowered by analysts at JPMorgan Chase & Co. from $47.00 to $41.00. They now have an “overweight” rating on the stock.
• 4/9/2025 – Bath & Body Works was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $35.00 price target on the stock, down previously from $38.00.
• 4/7/2025 – Bath & Body Works had its price target lowered by analysts at Citigroup Inc. from $48.00 to $36.00. They now have a “buy” rating on the stock.
• 3/3/2025 – Bath & Body Works had its price target lowered by analysts at Barclays PLC from $43.00 to $38.00. They now have an “equal weight” rating on the stock.
• 2/28/2025 – Bath & Body Works had its price target raised by analysts at Robert W. Baird from $45.00 to $47.00. They now have an “outperform” rating on the stock.
• 2/28/2025 – Bath & Body Works was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $48.00 price target on the stock, up previously from $40.00.
• 2/27/2025 – Bath & Body Works had its “buy” rating reaffirmed by analysts at Cowen Inc.
• 2/27/2025 – Bath & Body Works was given a new $47.00 price target on by analysts at JPMorgan Chase & Co..
• 2/27/2025 – Bath & Body Works had its “outperform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $43.00 price target on the stock.

Bath & Body Works Trading Down 0.5 %

BBWI stock opened at $29.61 on Monday. The firm has a 50 day moving average of $31.33 and a 200-day moving average of $33.86. The company has a market cap of $6.34 billion, a price-to-earnings ratio of 7.22, a PEG ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 12-month low of $24.96 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.70%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s payout ratio is currently 21.98%.

Institutional Trading of Bath & Body Works

Several large investors have recently modified their holdings of BBWI. SRS Capital Advisors Inc. lifted its stake in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after buying an additional 329 shares in the last quarter. Golden State Wealth Management LLC acquired a new position in shares of Bath & Body Works in the fourth quarter worth $26,000. UMB Bank n.a. lifted its position in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Lindbrook Capital LLC boosted its stake in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after acquiring an additional 431 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its holdings in Bath & Body Works by 135.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company’s stock valued at $39,000 after purchasing an additional 582 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.